NEOADJUVANT GEMCITABINE PLUS CARBOPLATIN FOLLOWED BY IMMEDIATE RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A PROPENSITY SCORE ANALYSIS

被引:0
|
作者
Koie, Takuya
Okamoto, Akiko
Yamamoto, Hayato
Tobisawa, Yuki
Yoneyama, Tohru
Mori, Kazuyuki
Hatakeyama, Shingo
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Kamimura, Noritaka
Ohyama, Chikara
机构
来源
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词
D O I
10.1016/j.juro.2012.02.602
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
529
引用
收藏
页码:E217 / E218
页数:2
相关论文
共 50 条
  • [21] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [22] Muscle-Invasive Bladder Cancer and Radical Cystectomy
    Hakenberg, Oliver W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (01) : 1 - 1
  • [23] Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis
    Kim, Yeon Joo
    Byun, Sang Jun
    Ahn, Hanjong
    Kim, Choung-Soo
    Hong, Beom-Sik
    Yoo, Sangjun
    Lee, Jae-Lyun
    Kim, Young Seok
    ONCOTARGET, 2017, 8 (40) : 68996 - 69004
  • [24] Propensity-score matched survival analysis of octogenarians with muscle-invasive bladder cancer: Chemoradiation compared to radical cystectomy
    Ganapathi, H.
    Prabhakar, P.
    Kulkarni, N.
    Eldefrawy, A.
    Caso, J.
    Manoharan, M.
    EUROPEAN UROLOGY, 2023, 83 : S217 - S218
  • [25] Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.
    Gupta, Shilpa
    Agarwal, Neeraj
    Konety, Badrinath R.
    Weight, Christopher J.
    Thyagarajan, Bharat
    Murugan, Paari J.
    Koopmeiners, Joseph S.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [26] DELAYED RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A NATIONWIDE ANALYSIS
    Bruins, Harman Maxim
    Aben, Katja
    Arends, Tom
    van der Heijden, Toine
    Witjes, Fred
    JOURNAL OF UROLOGY, 2015, 193 (04): : E810 - E811
  • [27] Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
    Pichler, Renate
    Fritz, Josef
    Mari, Andrea
    Cadenar, Anna
    von Deimling, Markus
    Marcq, Gautier
    del Giudice, Francesco
    Leonardo, Costantino
    Bologna, Eugenio
    Mori, Keiichiro
    Tahbaz, Rana
    De Santis, Maria
    Klatte, Tobias
    Erber, Barbara
    Lackner, Felizian
    Kronbichler, Andreas
    Seeber, Andreas
    Fisch, Margit
    Moschini, Marco
    Pradere, Benjamin
    Mertens, Laura S.
    ONCOLOGIST, 2024, 29 (11): : e1511 - e1522
  • [28] Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer
    Pierre-Louis Reignier
    Hélène Gauthier
    Christophe Hennequin
    Quiterie Aussedat
    Evanguelos Xylinas
    François Desgrandchamps
    Stéphane Culine
    Alexandra Masson-Lecomte
    Clément Dumont
    World Journal of Urology, 2023, 41 : 3249 - 3255
  • [29] Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer
    Reignier, Pierre-Louis
    Gauthier, Helene
    Hennequin, Christophe
    Aussedat, Quiterie
    Xylinas, Evanguelos
    Desgrandchamps, Francois
    Culine, Stephane
    Masson-Lecomte, Alexandra
    Dumont, Clement
    WORLD JOURNAL OF UROLOGY, 2023, 41 (11) : 3249 - 3255
  • [30] Delays in radical cystectomy for muscle-invasive bladder cancer
    Chu, Alice T.
    Holt, Sarah K.
    Wright, Jonathan L.
    Ramos, Jorge D.
    Grivas, Petros
    Yu, Evan Y.
    Gore, John L.
    CANCER, 2019, 125 (12) : 2011 - 2017